T:

Dominic Schmid1,2, Priska Auf der Maur3,4, Marcel P Trefny5

  • 1Department of Biomedicine, Laboratory Cancer Immunology, University of Basel, Basel, Switzerland.

Cancer research
|October 19, 2023
PubMed
概括

T细胞耗尽限制了免疫疗法的有效性. 一个新的体外模型和CRISPR查确定了BHLHE40作为T细胞耗尽进展的关键,提供了新的治疗点.